A first-in-human phase I, multicenter, open-label, dose-escalation study of the oral RAF/VEGFR-2 inhibitor (RAF265) in locally advanced or metastatic melanoma independent from BRAF mutation status
2017 ◽
Vol 6
(8)
◽
pp. 1904-1914
◽
Benjamin Izar
◽
William Sharfman
◽
F. Stephen Hodi
◽
Donald Lawrence
◽
Keith T. Flaherty
◽
...
2008 ◽
Vol 6
(12)
◽
pp. 130
◽
M.S. Gordon
◽
L.S. Rosen
◽
F. Robert
◽
D.S. Mendelson
◽
D. Kleinzweig
◽
...
2021 ◽
pp. clincanres.0845.2021
Adi Diab
◽
Omid Hamid
◽
John A Thompson
◽
Willeke Ros
◽
Ferry A.L.M. Eskens
◽
...
2008 ◽
Vol 6
(12)
◽
pp. 129
◽
R. Salgia
◽
A. Peterson
◽
S. Eppler
◽
W. Yu
◽
B. Polite
◽
...
A Diab
◽
O Hamid
◽
JA Thompson
◽
W Ros
◽
FALM Eskens
◽
...
Samuel C. Blackman
◽
Shelby D. Gainer
◽
Benjamin B. Suttle
◽
Konstantine W. Skordos
◽
Joel D. Greshock
◽
...
2018 ◽
Vol 29
◽
pp. viii234-viii235
◽
A.-L. Cheng
◽
C.-J. Yen
◽
T. Okusaka
◽
M. Ikeda
◽
C.-H. Hsu
◽
...
2004 ◽
Vol 22
(14_suppl)
◽
pp. 6594-6594
G. J. Weiner
◽
B. K. Link
◽
J. Leonard
◽
C. Emmanouilides
◽
G. Albert
◽
...
2011 ◽
Vol 29
(15_suppl)
◽
pp. 3033-3033
◽
A. L. Ho
◽
J. C. Bendell
◽
J. M. Cleary
◽
G. K. Schwartz
◽
H. A. Burris
◽
...
Drew Rasco
◽
Anthony Tolcher
◽
Lillian L. Siu
◽
Kimberley Heinhuis
◽
Sophie Postel-Vinay
◽
...
2014 ◽
Vol 2
(Suppl 3)
◽
pp. P86
◽
Herbert Hurwitz
◽
Todd Crocenzi
◽
Joanna Lohr
◽
Ezio Bonvini
◽
Syd Johnson
◽
...
Close
Export Citation Format
Close
Share Document
Close